Lena Innala

Reumatology Medicine (associated)

Publications

Author

Title

Year sorteringsordning

Fulltext

Innala, Lena
Sjöberg, Clara
Möller, Bozena; et al.

Co-morbidity in patients with early rheumatoid arthritis - inflammation matters
Arthritis Research & Therapy, 18

2016

Download

Innala, Lena
Sjöberg, C.
Berglin, Eva; et al.

Comorbidity in early rheumatoid arthritis - which is the role of inflammation?
Annals of the Rheumatic Diseases, 73: 406-406

2014

-

Innala, Lena

Early rheumatoid arthritis aspects of severity and co-morbidity

2014

Download

Innala, Lena
Berglin, Ewa
Möller, Bozena; et al.

Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study
Arthritis Research & Therapy, 16(2): R94-

2014

Download

Innala, Lena
Sjöberg, Clara
Berglin, Ewa H; et al.

Comorbidity in early rheumatoid arthritis: does inflammation matter?
Arthritis and Rheumatism, 65(Special issue, Supplement 10): S176-S176, Meeting Abstract: 408

2013

-

Innala, Lena
Möller, Bozena
Ljung, Lotta; et al.

Age at onset determines severity and choice of treatment in early rheumatoid arthritis
Arthritis and Rheumatism, 64(10): S908-S908

2012

-

Innala, Lena
Möller, Bozena
Ljung, Lotta; et al.

Cardiovascular events in early rheumatoid arthritis (RA) are a result of inflammatory burden and traditional risk factors: a five year prospective study
Arthritis Research & Therapy, 13(4): R131-

2011

Download

Innala, Lena
Kokkonen, Heidi
Eriksson, Catharina; et al.

Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides
Journal of Rheumatology, 35(6): 1002-1008

2008

-

Kokkonen, Heidi
Johansson, Martin
Innala, Lena; et al.

The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
Arthritis Research & Therapy, 9(5): 403-

2007

-